Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis.

[1]  H. A. Shah,et al.  Primary Biliary Cirrhosis , 2020, Definitions.

[2]  T. Barrientos-Gutiérrez,et al.  Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. , 2010, The Cochrane database of systematic reviews.

[3]  M. Navasa,et al.  Donor mannose‐binding lectin gene polymorphisms influence the outcome of liver transplantation , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  L. Stuart,et al.  Mannose‐binding lectin and innate immunity , 2009, Immunological reviews.

[5]  C. Mullighan,et al.  Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Mo Wang,et al.  Mannose-binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children , 2009, European Journal of Pediatrics.

[7]  M. Pirlich,et al.  Gastrointestinal tract in liver disease: which organ is sick? , 2008, Current opinion in clinical nutrition and metabolic care.

[8]  M. Boermeester,et al.  Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  G. Goulielmos,et al.  Mannose-binding Lectin MBL2 Gene Polymorphisms and Outcome of Hepatitis C Virus-infected Patients , 2008, Journal of Clinical Immunology.

[10]  R. Steffensen,et al.  Mannan‐binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy , 2008, Clinical and experimental immunology.

[11]  P. Tandon,et al.  Bacterial infections, sepsis, and multiorgan failure in cirrhosis. , 2008, Seminars in liver disease.

[12]  H. Nielsen,et al.  Biological Variation in Circulating Levels of Mannan‐Binding Lectin (MBL) and MBL‐Associated Serine Protease‐2 and the Influence of Age, Gender and Physical Exercise , 2007, Scandinavian journal of immunology.

[13]  M. Falagas,et al.  Bacterial Infection-Related Morbidity and Mortality in Cirrhosis , 2007, The American Journal of Gastroenterology.

[14]  M. Milanese,et al.  The expression of innate immunity genes in Italian Crohn disease patients. , 2007, European journal of histochemistry : EJH.

[15]  M. Paesmans,et al.  Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  W. Kim,et al.  The model for end‐stage liver disease (MELD) , 2007, Hepatology.

[17]  J. Ball,et al.  Severe fibrosis in hepatitis C virus‐infected patients is associated with increased activity of the mannan‐binding lectin (MBL)/MBL‐associated serine protease 1 (MASP‐1) complex , 2006, Clinical and experimental immunology.

[18]  N. Klein,et al.  Mannose‐binding lectin in innate immunity: past, present and future , 2006, Tissue antigens.

[19]  M. Riera,et al.  Mannose‐binding lectin does not act as an acute‐phase reactant in adults with community‐acquired pneumococcal pneumonia , 2006, Clinical and experimental immunology.

[20]  H. Caron,et al.  The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. , 2006, European journal of cancer.

[21]  P. Garred,et al.  Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. , 2006, Molecular immunology.

[22]  W. Ip,et al.  Mannose‐binding lectin in chronic hepatitis B virus infection , 2005, Hepatology.

[23]  C. Mullighan,et al.  Mannose‐binding lectin: biology and clinical implications , 2005, Internal medicine journal.

[24]  P. de Knijff,et al.  Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. , 2005, Gastroenterology.

[25]  S. Heatley,et al.  Mannose Binding Lectin Acute Phase Activity in Patients with Severe Infection , 2005, Journal of Clinical Immunology.

[26]  D. Valla,et al.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. , 2005, Journal of hepatology.

[27]  A. Burroughs,et al.  Infection, coagulation, and variceal bleeding in cirrhosis , 2005, Gut.

[28]  D. Eisen,et al.  Impact of mannose-binding lectin on susceptibility to infectious diseases. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  S. Thiel,et al.  Collections and ficolins: humoral lectins of the innate immune defense. , 2003, Annual review of immunology.

[30]  C. Koch,et al.  Immature dendritic cells possess a sugar‐sensitive receptor for human mannan‐binding lectin , 2003, Immunology.

[31]  M. Turner,et al.  Mannan‐binding lectin and hepatitis C infection , 2003, Clinical and experimental immunology.

[32]  C. Mullighan,et al.  Analysis of the Relationship Between Mannose‐Binding Lectin (MBL) Genotype, MBL Levels and Function in an Australian Blood Donor Population , 2002, Scandinavian journal of immunology.

[33]  A. Tanaka,et al.  Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis. , 2001, Journal of autoimmunity.

[34]  N. Klein,et al.  Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study , 2001, The Lancet.

[35]  P. Angeli,et al.  Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[36]  D. Jack,et al.  Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. , 2000, Gastroenterology.

[37]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[38]  T. Poynard,et al.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta‐analysis , 1999, Hepatology.

[39]  T. Ueno,et al.  Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. , 1993, The American journal of gastroenterology.

[40]  M. Turner,et al.  Mannan-binding lectin genotypes and genotype-phenotype relationships in a large cohort of Polish neonates. , 2009, Human immunology.

[41]  M. Manns,et al.  The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy. , 2008, Journal of hepatology.

[42]  S. Thiel,et al.  Assays for the functional activity of the mannan-binding lectin pathway of complement activation. , 2002, Immunobiology.

[43]  L. Leibovici,et al.  Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. , 2002, The Cochrane database of systematic reviews.

[44]  E. Strauss,et al.  A prospective study of bacterial infections in patients with cirrhosis. , 1993, Journal of hepatology.

[45]  Marshall M. Kaplan.  Primary biliary cirrhosis. , 1987, The New England journal of medicine.